Search for Clinical Trial Results
End Stage Liver Disease - 26 Studies Found
Status | Study |
Withdrawn |
Study Name: Study of Peripheral Tissue Oxygenation in End-stage Liver Disease Patients During Liver Transplantation Condition: End Stage Liver Disease Date: 2013-01-17 |
Completed |
Study Name: End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA) Condition: End Stage Liver Disease Date: 2006-09-08 Interventions:
|
Completed |
Study Name: Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease Condition: End Stage Liver DIsease Date: 2012-10-11 Interventions: Drug: Mobilization with G-CSF and Mozobil Treatment with drugs for mobilization of MSCs |
Completed |
Study Name: Procurement of Leukapheresis Products From End Stage Liver Disease (ESLD) Patients for Immunological Studies Condition: End Stage Liver Disease Date: 2015-04-17 Interventions: Procedure: Leukapheresis Catheter placement will occur for |
Recruiting |
Study Name: To Study the Immunomodulating Effects and Safety Profile of ω3 and ω6 PUFA Containing Intravenous Lipid Emulsion in Patients With Acute on Chronic Liver Failure Condition: Chronic Liver Failure Date: 2016-02-15 Interventions:
|
Recruiting |
Study Name: Granulocyte Colony Stimulating Factor (G-CSF) to Treat Acute-on-chronic Liver Failure Condition: Acute-On-Chronic Liver Failure Date: 2016-01-22 Interventions:
|
Recruiting |
Study Name: To Study the Influence of GCSF on Natural History of Acute On Chronic Liver Failure After the Acute Phase Condition: Acute on Chronic Liver Failure Date: 2016-03-22 Interventions:
|
Recruiting |
Study Name: Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction In Acute-On-Chronic Liver Failure. Condition: Acute on Chronic Liver Failure Date: 2015-06-04 Interventions:
|
Not yet recruiting |
Study Name: Safety and Performance Trial of DIALIVE Liver Dialysis Device in Acute On Chronic Liver Failure Patients Condition: Acute on Chronic Liver Failure Date: 2017-01-18 Interventions: Device: DIALIVE Liver Dialysis Device ACLF patients will receive dialysis treatment for 8-12 hrs/day and |
Completed |
Study Name: Assessment of Coagulation Profile and Haematopoietic Responses in Patients With Acute-on-chronic Liver Failure During Systemic Inflammatory Response (SIRS) and Sepsis Condition: Acute on Chronic Liver Failure Date: 2014-11-18 Interventions: Other: Sonoclot/TEG test The Sonoclot/TEG test will be done at the study time points. Within 12 hours of |